Letters to the Editor

‘Generally Safe’ NSAIDs?

Am Fam Physician. 2001 Feb 15;63(4):637-638.

to the editor: When will we ever learn? Physicians, patients and society have become so used to over-the-counter and prescription non-steroidal anti-inflammatory drugs (NSAIDs) as an everyday fact of life that we have become numbed to the devastation they cause. In “Cyclooxygenase-2 Enzyme Inhibitors: Place in Therapy,”1 the authors, in an otherwise excellent article, state: “Although generally safe, ‘traditional’ NSAIDs account for almost one fourth of all reported adverse drug events. Approximately 15 percent of NSAID users have gastrointestinal tract symptoms such as dyspepsia, heartburn, nausea or vomiting. Each year, 1 to 4 percent of NSAID users have serious gastrointestinal tract complications such as hemorrhage, with an estimated cost of $15,000 to $20,000 per hospitalization. An estimated 16,500 NSAID-related deaths occur annually among patients with osteoarthritis or rheumatoid arthritis. Medical costs of complications associated with NSAID use exceed $4 billion annually.”1

Since when are 16,500 deaths, $4 billion dollars in complications and a 15 percent rate of gastrointestinal complications including gastrointestinal hemorrhage and other debilitating and potentially lethal side effects considered “generally safe”? The authors did not mention renal, liver and other associated toxicities.

It's time we think of these medications as the dangerous and potentially lethal drugs they are. When we supervise a resident who casually prescribes ibuprofen to an elderly patient or when we ourselves feel pressed to find an easy answer to a throbbing back or head pain in a hypertensive patient we should think “danger” not “generally safe.”

REFERENCE

Noble SL, King SD, Outade JI. Cyclooxygenase-2 enzyme inhibitors: place in therapy. Am Fam Physician. 2000;61:3669–76.

in reply :Dr. Rosen makes an excellent point. Perhaps the word “considered” should be inserted between the words “generally” and “safe.” This article1 tried to convey the significance of adverse events due to NSAID therapy by presenting the startling facts of NSAID-induced morbidity and mortality in that same paragraph.

In an earlier version of the article, the abstract did contain the sentence “NSAIDs can also adversely influence blood pressure control, the central nervous system, and cause renal complications.” As the article went through medical and copy editing, this sentence was deleted. It was felt that family physicians are aware of the common adverse effects that NSAID therapy may cause. I appreciate your concern and would like to echo that NSAID therapy, although generally considered safe, indeed is not without significant risks.

REFERENCES

Noble SL, King SD, Outade JI. Cyclooxygenase-2 enzyme inhibitors: place in therapy. Am Fam Physician. 2000;61:3669–76.

Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: afplet@aafp.org, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.

Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.

Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.


Copyright © 2001 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

Navigate this Article